Idiopathic and secondary membranous nephropathy and polymorphism at TAP1 and HLA-DMA loci

Tissue Antigens

Volumn 50, Issue 2, 1997, Pages 164-169

  Chevrier, D ^a   Giral, M ^b   Perrichot, R ^c   Latinne, D ^d   Coville, P ^e   Muller, J Y ^a   Soulillou, J P ^b   Bignon, J D ^a  

^a Laboratoire HLA   (France)

^b INSERM   (France)

^c SERVICE DE RHUMATOLOGIE   (France)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^e Centre Hospitalier Chubert   (France)

Author keywords

DM; HLA; LMP; Major histocompatibility complex; Membranous nephropathy; TAP

Indexed keywords

CYCLOPHOSPHAMIDE; GLYCINE; HLA D ANTIGEN; STEROID; VALINE;

ADULT; ARTICLE; CONTROLLED STUDY; GENE LINKAGE DISEQUILIBRIUM; GLOMERULOPATHY; HISTOCOMPATIBILITY; HLA TYPING; HUMAN; HUMAN CELL; IDIOPATHIC DISEASE; IMMUNOGENETICS; KIDNEY ALLOGRAFT; KIDNEY DISEASE; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030835436     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1997.tb02855.x     Document Type: Article

References (39)

1. Lewis EJ. Management of the nephrotic syndrome in adults. In: Cameron JS, Glassock RJ, ed. The nephrotic syndrome. New York: Marcel Dekker, 1988: 461-521.
2. Kingswood JC, Banks RA, Tribe R, Owen-Jones J, MacKenzie JC. Renal biopsy in the elderly. Clinicopathological correlations in 143 patients. Clin Nephrol 1984: 22: 183-187.
3. Zucchelli P, Pasquali S. Membranous nephropathy. In: Cameron S, Davidson AM, Grünfeld JP, Carre D, Ritz E, ed. Oxford text book of clinical nephrology. Oxford: Oxford Medical Publications, 1992: 370-388.
4. Papiha SS, Pareek SK, Rodeg RS et al. HLA -A,B,DR and Bf allotypes in patients with idiopathic membranous nephropathy (IMN). Kidney Int 1987: 31: 130-134.
5. Trowsdale J, Hanson I, Mockridge I, Beck S, Townsend A, Kelly A. Sequences encoded in the class II region of the MHC related to the "ABC" superfamily of transporters. Nature 1990: 348: 741-744.
6. Spies T, Bresnahan M, Bahram S et al. A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature 1990: 348: 744-747.
7. Colonna M, Bresnahan M, Bahram S, Strominger JL, Spies T. Allelic variants of the human putative peptide transporter involved in antigen processing. Proc Natl Acad Sci U S A 1992: 89: 3932-3936.
8. Powis SH, Tonks S, Mockridge I, Kelly AP, Trowsdale J. Alleles and haplotypes of the MHC encoded ABC transporters TAP1 and TAP2. Immunogenetics 1993: 37: 373-380.
9. Kleijmeer MJ, Kelly A, Geuze HJ, Slot JW, Townsend A, Trowsdale J. Location of MHC-encoded transporters in the endoplasmic reticulum and cis-Golgi. Nature 1992: 357: 342-344.
10. Neeffjes JJ., Mombourg F, Hämmerling GJ. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science 1993: 261: 769-771.
11. + T cells. Cell 1992: 71: 1205-1214.
12. De la Salle H, Hanau D, Fricker D et al. Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science 1994: 265: 237-241.
13. Powis SJ, Deverson EV, Coadwell WJ et al. Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule. Nature 1992: 357: 211-215.
14. Kelly A, Powis SH, Glynne R, Radley E, Beck S, Trowsdale J. Second proteasome-related gene in the human MHC class II region. Nature 1991: 353: 667-668.
15. Glynne R, Powis SH, Beck S, Kelly A, Kerr L-A, Trowsdale J. A proteasome-related gene in the human MHC class II region. Nature 1991: 353: 357-360.
16. Robertson M. Proteasomes in the pathway. Nature 1991: 353: 300-301.
17. Deng GY, Muir A, Maclaren NK, She J-X. Association of LMP2 and LMP7 genes within the major histocompatibility complex with insulin-dependent diabetes mellitus: population and family studies. Am J Hum Genet 1995: 56: 528-534.
18. Früh K, Yang Y, Arnold D et al. Alternative exon usage and processing of the major histocompatibility complex-encoded proteasome subunits. J Biol Chem 1992: 267: 22131-22140.
19. Glynne R, Kerr CA, Mockridge I, Beck S, Kelly A. Trowsdale J. The major histocompatibility complex-encoded proteasome component LMP7: alternative first exons and post-translational processing. Eur J Immunol 1993: 23: 860-866.
20. Kelly AP, Monaco JJ, Cho S, Trowsdale J. A new human HLA class II-related locus, DM. Nature 1991: 353: 571-573.
21. Radley E, Alderton RP, Kelly A, Trowsdale J, Beck S. Genomic organisation of HLA-DMA and HLA-DMB. Comparison of the gene organisation of the all six class II families in the human major histocompatibility complex. J Biol Chem 1994: 269: 18834-18838.
22. Fling SP, Arp B, Pious D. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature 1994: 368: 554-558.
23. Sloan VS, Cameron P, Porter G et al. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 1995: 375: 802-806.
24. Denzin LK, Cresswell P. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 1995: 82: 155-165.
25. Carrington M, Harding A. Sequence analysis of two novel HLA-DMA alleles. Immunogenetics 1994: 40: 165.
26. Carrington M, Yeager M, Mann D. Characterization of HLA-DMB polymorphism. Immunogenetics 1993: 38: 446-449.
27. Chevrier D, Giral M, Braud V et al. Effects of MHC-encoded TAP1 and TAP2 gene polymorphism and matching on kidney graft rejection. Transplantation 1995: 60: 292-296.
28. Chevrier D, Giral M, Braud V, Soulillou JP, and Bignon JD. Membranous nephropathy and a TAP1 gene polymorphism. N Engl J Med 1994: 331: 133-134 (letter).
29. Kimura A, Sasazuki T. 11th International Histocompatibility Workshop reference protocol for the DNA-typing technique. In: Sasazuki et al. ed. HLA 1992, Vol. 1. Oxford: Oxford University Press, 1992.
30. Newton CR, Graham A, Heptinstall LE et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 1989: 17: 2503-2516.
31. Teisserenc H, Charron D. Technical handbook of the Twelfth International Histocompatibility Workshop. Addendum 12-1994. Charron D, Fauchet R, ed. Paris: HLA et Médecine, 1994.
32. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1956: 20: 309.
33. Mattiuz PH, Ihde D, Piazza A, Ceppellini R, Bodmer WF. New approaches to the population genetic and segregation analysis of the HLA system. Histocompatibility testing 1970. Copenhagen: Munksgaard, 1970: 193-205.
34. Klouda PT, Manos J, Acheson EJ et al. Strong association between idiopathic membranous nephropathy and HLA-Dw3. Lancet 1979: ii: 770-771.
35. Schieppati A, Mosconi L, Perna A et al. Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med 1993: 329: 85-89.
36. Obst R, Armandola EA, Nijenhuis M, Momburg F, Hämmerling GJ. TAP polymorphism does not influence transport of peptide variants in mice and humans. Eur J Immunol 1995: 25: 2170-2176.
37. Carmichael P, Kerr L-A, Kelly A et al. The TAP complex influences allorecognition of class II MHC molecules. Hum Immunol 1996: 50: 70-77.
38. Sanderson F, Powis SH, Kelly AP, Trowsdale J. Limited polymorphism in HLA-DM does not involve the peptide binding groove. Immunogenetics 1994: 39: 56-58.
39. Kida H, Asamoto T, Yokoyama H, Tomosugi N, Hattori N. Long term prognosis of membranous nephropathy. Clin Nephrol 1986: 25: 64.